Precigen (PGEN) Shares Outstanding (Weighted Average) (2011 - 2026)

Precigen (PGEN) has 16 years of Shares Outstanding (Weighted Average) data on file, last reported at $354.3 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $354.3 million, up 572.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $354.3 million (up 572.7% YoY), and the FY2025 annual result was $313.0 million, up 16.9% from the prior year.
• Shares Outstanding (Weighted Average) advanced to $354.3 million in Q1 2026 per PGEN's latest filing, from $313.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $354.3 million in Q1 2026 and troughed at $52.7 million in Q1 2025.
• A 5-year average of $227.5 million and a median of $243.1 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) plunged 79.13% in 2025, then soared 572.7% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $200.4 million in 2022, then climbed by 22.05% to $244.5 million in 2023, then gained by 9.48% to $267.7 million in 2024, then rose by 16.9% to $313.0 million in 2025, then grew by 13.2% to $354.3 million in 2026.
• Business Quant data shows PGEN's Shares Outstanding (Weighted Average) at $354.3 million in Q1 2026, $313.0 million in Q4 2025, and $307.2 million in Q3 2025.